Way Forward
startup series
need to undertake R & D activities too . In order to effectively address all such urgent requirements , we are in urgent need of a huge amount of money in crores along with the expertise resources , which we are clearly lacking and finding no active platform which may support us in accomplishing our pious and visionary mission .”
Way Forward
The statistics reveal that more than 2.5 billion syringes were used in 2010 which are forecasted to grow by 10 % annually . Potential market of syringes is expected to increase from USD 10.56 billion in 2016 to USD 15.99 billion in 2021 at a growth rate of 8.7 %.
“ Despite all market constraints i . e . costs , procurement structure etc . will be negated by our technology to effectively meet the rising global demand ,” says Bharati adding that “ We are keeping all our sincere efforts underway to commercially exploit our invention , so that the real benefits of the technology may reach to the endusers . We are also building global network and arranging necessary funds , resources , expertise etc . to commercialize our innovation globally .”
Bharati reveals that they have quite lucrative offers from big companies , but are afraid of shelving ’ of their technology . They have planned to commercialize it through licensing model at our own . Therefore , these are very testing times for them as they have to stay focused on their goals without much funds and at the same time also not get swayed by false promises . “ We are zealously trying to become a part of the most ambitious ‘ Make in India ’ regime of Government of India . We have seriously planned to adopt Licensing model for commercialization and revenue generation ,” she says .
The company has voluntarily offered a free of cost license to WHO , UNICEF and RED-CROSS to use its invention globally for the well-being of public at large , so that the ultimate benefits of invention may directly reach to the end-users in urgent need . The innovators expect that the Indian industries will come forward with open heart to support us in commercializing our innovation keeping in view the paramount consideration of national interest . Hopefully , they will not get disappointed .
68 BioVoiceNews | August 2017